Irritable bowel syndrome: Difference between revisions
(→Workup) |
|||
| Line 24: | Line 24: | ||
==Management== | ==Management== | ||
*Consider prescribing [[ondansetron]] up to 24 mg/d for IBS-D<ref>Garsed K, Chernova J, Hastings M, et al. A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut. 2014;63:1617-1625.</ref> | |||
==See Also== | ==See Also== | ||
Revision as of 01:31, 2 October 2018
Background
- psychosocial factors
- altered gut motility
- hypersensitive intestinal pain perseption
Evaluation
Criteria
- Three months of pain:
- relieved by defecation
- associated with change of stool freq
- related to a change in stool consistency
- AND, 2 or more of the following symptoms 25% of the time
- >3 bm per day or < 3 bm per week
- altered stool form
- altered stool passage
- passage of mucous
- bloating
Workup
- Diagnosis of exclusion
Differential Diagnosis
Management
- Consider prescribing ondansetron up to 24 mg/d for IBS-D[1]
See Also
External Links
Patient Information
Irritable Bowel Syndrome (National Digestive Diseases Information Clearinghouse)
References
- ↑ Garsed K, Chernova J, Hastings M, et al. A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut. 2014;63:1617-1625.